{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T08:54:07Z","timestamp":1784710447306,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Updates Surg"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s13304-024-01985-2","type":"journal-article","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T09:29:50Z","timestamp":1727170190000},"page":"2885-2892","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Comparison of five scores to predict mortality in malignant pleural effusion"],"prefix":"10.1007","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3106-7403","authenticated-orcid":false,"given":"Merve","family":"Ayik T\u00fcrk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2211-1268","authenticated-orcid":false,"given":"G\u00fclru","family":"Polat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2446-5139","authenticated-orcid":false,"given":"\u00d6zer","family":"\u00d6zdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2254-889X","authenticated-orcid":false,"given":"Yunus","family":"T\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2877-242X","authenticated-orcid":false,"given":"Berna","family":"K\u00f6m\u00fcrc\u00fco\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,23]]},"reference":[{"key":"1985_CR1","doi-asserted-by":"publisher","first-page":"1800349","DOI":"10.1183\/13993003.00349-2018","volume":"52","author":"AC Bibby","year":"2018","unstructured":"Bibby AC, Dorn P, Psallidas I et al (2018) ERS\/EACTS statement on the management of malign pleural effusions. Eur Respir J 52:1800349. https:\/\/doi.org\/10.1183\/13993003.00349-2018","journal-title":"Eur Respir J"},{"key":"1985_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2147\/CMAR.S95663","volume":"9","author":"E Penz","year":"2017","unstructured":"Penz E, Watt KN, Hergott CA, Rahman NM, Psallidas I (2017) Management of malignant pleural effusion: challenges and solutions. Cancer Manag. Res. 9:229\u2013241. https:\/\/doi.org\/10.2147\/CMAR.S95663","journal-title":"Cancer Manag. Res."},{"issue":"4","key":"1985_CR3","first-page":"145","volume":"6","author":"JM Matilla","year":"2020","unstructured":"Matilla JM, Zabaleta M, Mart\u00ednez-T\u00e9llez E, Abal J, Rodr\u00edguez-Fuster A, Hern\u00e1ndez-Hern\u00e1ndez J (2020) New TNM staging in lung cancer (8th edition) and future perspectives. J Clin Transl Res. 6(4):145\u2013154","journal-title":"J Clin Transl Res."},{"key":"1985_CR4","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1183\/13993003.00349-2018","volume":"55","author":"AC Bibby","year":"2019","unstructured":"Bibby AC, Dorn P, Psallidas I et al (2019) ERS\/EACTS statement on the management of malignant pleural effusions. Eur J Cardiothorac Surg 55:116\u2013132. https:\/\/doi.org\/10.1183\/13993003.00349-2018","journal-title":"Eur J Cardiothorac Surg"},{"key":"1985_CR5","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1513\/AnnalsATS.201609-709OC","volume":"14","author":"J Carter","year":"2017","unstructured":"Carter J, Miller JA, Feller-Kopman D, Ettinger D, Sidransky D, Maleki Z (2017) Molecular profiling of malignant pleural effusion in metastatic non-small-cell lung carcinoma the effect of preanalytical factors. Ann Am Thorac Soc 14:1169\u20131176. https:\/\/doi.org\/10.1513\/AnnalsATS.201609-709OC","journal-title":"Ann Am Thorac Soc"},{"issue":"Suppl. 2","key":"1985_CR6","doi-asserted-by":"publisher","first-page":"ii32","DOI":"10.1136\/thx.2010.136994","volume":"65","author":"ME Roberts","year":"2010","unstructured":"Roberts ME, Neville E, Berrisford RG et al (2010) Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010. Thorax 65(Suppl. 2):ii32\u2013ii40. https:\/\/doi.org\/10.1136\/thx.2010.136994","journal-title":"Thorax"},{"key":"1985_CR7","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1136\/thoraxjnl-2014-205285","volume":"69","author":"AO Clive","year":"2014","unstructured":"Clive AO, Kahan BC, Hooper CE et al (2014) Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score. Thorax 69:1098\u20131104. https:\/\/doi.org\/10.1136\/thoraxjnl-2014-205285","journal-title":"Thorax"},{"issue":"7","key":"1985_CR8","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/0959-8049(95)00664-8","volume":"32A","author":"G Buccheri","year":"1996","unstructured":"Buccheri G, Ferrigno D, Tamburini M (1996) Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution. Eur J Cancer 32A(7):1135\u20131141. https:\/\/doi.org\/10.1016\/0959-8049(95)00664-8","journal-title":"Eur J Cancer"},{"issue":"8","key":"1985_CR9","doi-asserted-by":"publisher","first-page":"490","DOI":"10.3390\/medicina55080490","volume":"55","author":"K Skok","year":"2019","unstructured":"Skok K, Hladnik G, Grm A, Crnjac A (2019) Malignant pleural effusion and its current management: a review. Medicina (Kaunas) 55(8):490. https:\/\/doi.org\/10.3390\/medicina55080490","journal-title":"Medicina (Kaunas)"},{"issue":"7","key":"1985_CR10","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/S1470-2045(18)30294-8","volume":"19","author":"I Psallidas","year":"2018","unstructured":"Psallidas I, Kanellakis NI, Gerry S et al (2018) Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis. Lancet Oncol 19(7):930\u2013939. https:\/\/doi.org\/10.1016\/S1470-2045(18)30294-8","journal-title":"Lancet Oncol"},{"issue":"3","key":"1985_CR11","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.21037\/tlcr-20-1191","volume":"10","author":"T Zhang","year":"2021","unstructured":"Zhang T, Chen X, Wan B et al (2021) Development of RECLS score to predict survival in lung cancer patients with malignant pleural effusion. Transl Lung Cancer Res. 10(3):1318\u20131326. https:\/\/doi.org\/10.21037\/tlcr-20-1191","journal-title":"Transl Lung Cancer Res."},{"issue":"2","key":"1985_CR12","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/1759-7714.13262","volume":"11","author":"XY Shi","year":"2020","unstructured":"Shi XY, Yi FS, Wang Z, Qiao X, Zhai K (2020) Prognostic value of a new score using serum alkaline phosphatase and pleural effusion lactate dehydrogenase for patients with malignant pleural effusion. Thorac Cancer. 11(2):320\u2013328. https:\/\/doi.org\/10.1111\/1759-7714.13262","journal-title":"Thorac Cancer."},{"key":"1985_CR13","unstructured":"MedCalc\u00ae Statistical Software version 22.018 (MedCalc Software Ltd, Ostend, Belgium; https:\/\/www.medcalc.org; 2024). Accessed 16 Jan 2024."},{"key":"1985_CR14","doi-asserted-by":"publisher","first-page":"106650","DOI":"10.1016\/j.rmed.2021.106650","volume":"189","author":"C Wong","year":"2021","unstructured":"Wong C, Wing-Cheuk Wong R, Kit-Ying So L, Yin-Chun YL (2021) Evaluation of prognostication scores and proposal for refinement in malignant pleural effusion in Asians. Respir Med 189:106650. https:\/\/doi.org\/10.1016\/j.rmed.2021.106650","journal-title":"Respir Med"},{"issue":"12","key":"1985_CR15","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1111\/resp.13837","volume":"25","author":"JC Quek","year":"2020","unstructured":"Quek JC, Tan QL, Allen JC, Anantham D (2020) Malignant pleural effusion survival prognostication in an Asian population. Respirology 25(12):1283\u20131291. https:\/\/doi.org\/10.1111\/resp.13837","journal-title":"Respirology"},{"issue":"4","key":"1985_CR16","doi-asserted-by":"publisher","first-page":"325","DOI":"10.4103\/lungindia.lungindia_633_21","volume":"39","author":"S Ermin","year":"2022","unstructured":"Ermin S, \u00d6zdogan Y, Batum \u00d6, Yilmaz U (2022) The role of LENT and PROMISE scores in predicting survival in malignant pleural effusion. Lung India 39(4):325\u2013330. https:\/\/doi.org\/10.4103\/lungindia.lungindia_633_21","journal-title":"Lung India"},{"key":"1985_CR17","first-page":"47","volume":"3","author":"S Sugiura","year":"1997","unstructured":"Sugiura S, Ando Y, Minami H, Ando M, Sakai S, Shimokata K (1997) Prognostic value of pleural effusion in patients with non-small cell lung cancer. Clin Cancer Res 3:47\u201350","journal-title":"Clin Cancer Res"},{"key":"1985_CR18","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1183\/09031936.00069812","volume":"41","author":"SG Wu","year":"2013","unstructured":"Wu SG, Yu CJ, Tsai MF et al (2013) Survival of lung adenocarcinoma patients with malignant pleural effusion. Eur Respir J 41:1409\u20131418. https:\/\/doi.org\/10.1183\/09031936.00069812","journal-title":"Eur Respir J"},{"issue":"3","key":"1985_CR19","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1378\/chest.127.3.909","volume":"127","author":"CM Dresler","year":"2005","unstructured":"Dresler CM, Olak J, Herndon JE 2nd et al (2005) Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest 127(3):909\u2013915. https:\/\/doi.org\/10.1378\/chest.127.3.909","journal-title":"Chest"},{"issue":"1","key":"1985_CR20","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1186\/s12885-017-3550-8","volume":"17","author":"YS Lee","year":"2017","unstructured":"Lee YS, Nam HS, Lim JH et al (2017) Prognostic impact of a new score using neutrophil-to-lymphocyte ratios in the serum and malignant pleural effusion in lung cancer patients. BMC Cancer 17(1):557. https:\/\/doi.org\/10.1186\/s12885-017-3550-8","journal-title":"BMC Cancer"},{"issue":"4","key":"1985_CR21","doi-asserted-by":"publisher","first-page":"e0250628","DOI":"10.1371\/journal.pone.0250628","volume":"16","author":"N Popowicz","year":"2021","unstructured":"Popowicz N, Cheah HM, Gregory C et al (2021) Neutrophil-to-lymphocyte ratio in malignant pleural fluid: Prognostic significance. PLoS ONE 16(4):e0250628. https:\/\/doi.org\/10.1371\/journal.pone.0250628","journal-title":"PLoS ONE"},{"issue":"1","key":"1985_CR22","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.critrevonc.2013.03.010","volume":"88","author":"GJ Guthrie","year":"2013","unstructured":"Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ (2013) The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol 88(1):218\u2013230. https:\/\/doi.org\/10.1016\/j.critrevonc.2013.03.010","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"1985_CR23","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.21873\/invivo.12027","volume":"34","author":"JU Lim","year":"2020","unstructured":"Lim JU, Yeo CD, Kim HW et al (2020) Pleural neutrophil-to-lymphocyte ratio may be associated with early disease progression in stage IV non-small cell lung cancer. In Vivo 34(4):2179\u20132185. https:\/\/doi.org\/10.21873\/invivo.12027","journal-title":"In Vivo"},{"issue":"34","key":"1985_CR24","doi-asserted-by":"publisher","first-page":"57460","DOI":"10.18632\/oncotarget.15404","volume":"8","author":"N Chen","year":"2017","unstructured":"Chen N, Liu S, Huang L et al (2017) Prognostic significance of neutrophil-to-lymphocyte ratio in patients with malignant pleural mesothelioma: a meta-analysis. Oncotarget 8(34):57460\u201357469. https:\/\/doi.org\/10.18632\/oncotarget.15404","journal-title":"Oncotarget"},{"issue":"12","key":"1985_CR25","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1136\/thoraxjnl-2014-206194","volume":"69","author":"J Murray","year":"2014","unstructured":"Murray J, Turner R, Bothamley GH, Bhowmik A (2014) A response to the LENT score. Thorax 69(12):1144. https:\/\/doi.org\/10.1136\/thoraxjnl-2014-206194","journal-title":"Thorax"},{"issue":"12","key":"1985_CR26","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1136\/thoraxjnl-2014-206247","volume":"69","author":"AO Clive","year":"2014","unstructured":"Clive AO, Kahan BC, Maskell NA (2014) Authors\u2019 response to Murray et al. Thorax 69(12):1144\u20131145. https:\/\/doi.org\/10.1136\/thoraxjnl-2014-206247","journal-title":"Thorax"},{"issue":"1","key":"1985_CR27","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12943-023-01740-y","volume":"22","author":"A Lahiri","year":"2023","unstructured":"Lahiri A, Maji A, Potdar PD et al (2023) Lung cancer immunotherapy: progress, pitfalls, and promises. Mol Cancer 22(1):40. https:\/\/doi.org\/10.1186\/s12943-023-01740-y","journal-title":"Mol Cancer"},{"issue":"5","key":"1985_CR28","doi-asserted-by":"publisher","first-page":"497","DOI":"10.6004\/jnccn.2022.0025","volume":"20","author":"DS Ettinger","year":"2022","unstructured":"Ettinger DS, Wood DE, Aisner DL et al (2022) Non-small cell lung cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 20(5):497\u2013530. https:\/\/doi.org\/10.6004\/jnccn.2022.0025","journal-title":"J Natl Compr Canc Netw"},{"issue":"11","key":"1985_CR29","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1111\/crj.13700","volume":"17","author":"T Li","year":"2023","unstructured":"Li T, Tian P, Huang Q, Zeng H, Wei Q, Li Y (2023) Development and validation of the CAIL prognostic score in non-small cell lung cancer patients with malignant pleural effusion. Clin Respir J 17(11):1158\u20131168. https:\/\/doi.org\/10.1111\/crj.13700","journal-title":"Clin Respir J"},{"issue":"6","key":"1985_CR30","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140(6):883\u2013899. https:\/\/doi.org\/10.1016\/j.cell.2010.01.025","journal-title":"Cell"},{"issue":"7","key":"1985_CR31","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.21037\/tlcr-23-7","volume":"12","author":"M Sung","year":"2023","unstructured":"Sung M, Jang WS, Kim HR et al (2023) Prognostic value of baseline and early treatment response of neutrophil-lymphocyte ratio, C-reactive protein, and lactate dehydrogenase in non-small cell lung cancer patients undergoing immunotherapy. Transl Lung Cancer Res. 12(7):1506\u20131516. https:\/\/doi.org\/10.21037\/tlcr-23-7","journal-title":"Transl Lung Cancer Res."}],"container-title":["Updates in Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-024-01985-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13304-024-01985-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-024-01985-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T15:16:59Z","timestamp":1733757419000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13304-024-01985-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,23]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1985"],"URL":"https:\/\/doi.org\/10.1007\/s13304-024-01985-2","relation":{},"ISSN":["2038-131X","2038-3312"],"issn-type":[{"value":"2038-131X","type":"print"},{"value":"2038-3312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,23]]},"assertion":[{"value":"27 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares there are no potential conflicts of interest. This article is protected by copyright. All rights reserved.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This is a retrospective study; local ethical approval was received with the ethical approval date and number 04\u201310-2023\/40\u201356. All procedures performed in studies involving human participants were carried out following the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was waived because of the retrospective nature of the study and the fact that no personal identifiers were included.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All procedures performed in studies involving human participants were carried out following the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}}]}}